Flavor-enhancing peptides for cocoa, coffee, and chocolate
Novel peptides designed to enhance the flavor profiles of cocoa, coffee, and chocolate, offering rich taste enhancements with minimal ingredient use. The peptides are set for further trials using proprietary manufacturing and FDA GRAS yeast production.
Overview
2D LLC presents a breakthrough in flavor enhancement with its innovative peptides designed specifically for cocoa, coffee, and chocolate. These peptides promise to deliver rich and complex taste profiles similar to sweet proteins like Brazzein but require only a minimal amount of the ingredient. This solution has the potential to revolutionize the flavor industry by providing a cost-effective and efficient way to enhance flavors without altering the natural taste of the products.
Technical specifications
- Flavor peptides: Specially formulated to enhance the taste of cocoa, coffee, and chocolate.
- Proprietary manufacturing: Utilizes unique processes to ensure the efficacy and stability of the peptides.
- FDA GRAS yeast production: Future trials will involve designing yeast capable of producing these peptides under FDA Generally Recognized As Safe (GRAS) standards.
Technology readiness level
Currently at TRL 3, these peptides have undergone initial validation and are moving towards further trial phases to establish commercial viability and safety standards.
About 2D LLC
CopX is a United States-based corporation focused on biotechnology and wellness products, including functional proteins, exosome preparations, and healthspan monitoring technologies. The company utilizes precision fermentation to produce proteins at scale, drawing on international research expertise to develop products aimed at supporting cellular function and mitigating age-related decline. Their portfolio includes 2D Functional Proteins, which are targeted blends designed to replenish essential peptides, and 2D Exomax, an exosome preparation derived from human umbilical cord mesenchymal stem cells for regenerative science applications. The company also promotes the 2DHeal network, which integrates health assessments such as AI-powered retinal imaging—using Airdoc camera technology—with their product offerings to provide personalized wellness insights.
By leveraging advanced manufacturing and diagnostic tools, CopX aims to support professional and research applications in health and integrative medicine. The company maintains international operational facilities for manufacturing and research, emphasizing scalability and sustainable production methods. Their model involves providing high-quality biological materials and screening services to health professionals and partners worldwide, focusing on addressing chronic inflammatory and degenerative health challenges. Through strategic collaborations and a emphasis on continuous production, CopX seeks to facilitate advancements in areas ranging from alternative proteins to biopharmaceuticals and personalized anti-aging protocols.
Inquire about this partnering listing
Industry applications
delivered to your inbox.